Zhengye Biotechnology Holding Limited

NASDAQ:ZYBT

Drug Manufacturers - Specialty & Generic

Healthcare
$1.50 +1047.56%

+$7.31 today

Market cap
$71.09M
Beta
-2.17
P/E (TTM)
-36.3
EPS (TTM)
-$1.50
52W Low $0.62High $13.08

Volume 0.02M

Average 0.10M

Returns on capital

Zhengye Biotechnology Holding Limited management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management

ROE

-27.9%

avg 3.6%

ROIC

-17.9%

avg 4.3%

ROA

-16.0%

avg 2.1%

Analysis

ROA is currently the strongest return metric at -16.0% versus its period average of 2.1%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Aiden Han

Co-Chief Executive Officer—330<0.01%

Songlin Song

Co-Chief Executive Officer—500<0.01%

Ping Wang

Chief Financial Officer—45——

Zhongyao Liu

Chief Operating Officer—400<0.01%

Yuhong Cheng

Vice General Manager—49——

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Jun 25, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

No open-market purchases or sales in the last 12 months.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A —
RevenueN/AN/A-23.5%
N/A —
Net IncomeN/AN/AN/A
N/A —
EBITN/AN/AN/A
N/A —

Analysis

Recent growth has been strongest in Revenue at -23.5% over three years.

Competitors

Who does Zhengye Biotechnology Holding Limited compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about ZYBT's management, answered from reported figures.

Who manages ZYBT?

Zhengye Biotechnology Holding Limited (ZYBT) lists 5 active executives. The top listed executive is Aiden Han, Co-Chief Executive Officer.

Are ZYBT insiders buying or selling?

Recent insider activity shows net buying of $0.00.